la jolla
-
Artificial Intelligence, BioPharma
Already Partnered With Nvidia, Iambic Adds $100M for AI Drug Discovery
Iambic Therapeutics brings together software engineers and drug-hunting scientists, all sharing the goal of using artificial intelligence to optimize properties of small molecule drugs. The startup will apply its Series B financing to a cancer drug pipeline that includes two candidates on track for the clinic in 2024.
-
Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation
Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Aira takes its Google Glass navigation for visually impaired to non-U.S. markets
In addition to airports, the company’s Google Glass-enabled technology has been used to help individuals navigate college campuses, train stations, and city centers.
-
An employer benefits adviser has launched a genomic testing advisory business
The goal of the La Jolla, California-based company, is to make genomic testing readily accessible and affordable for everyone through employer plans.
-
Venter steps down as CEO of Human Longevity
J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.
-
West Health CEO retiring; here’s what he’s accomplished
Nick Valeriani will retire as CEO of West Health in September, and be replaced by current COO Shelley Lyford, who also is president and CEO the Gary and Mary West Foundation, the entity that sponsors West Health.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.